π¨New ID PGY2 Alert at MedStar Health!π¨ Come meet with MedStar Health PGY1 and PGY2 residency programs at ASHP Midyear 12/09 at 1PM at booths 6605, 6607, 6611, 6612, 6613, 6614, and 6615. Please contact me if you have any questions or want to grab some coffee in Las Vegas 12/06-12/09 (my treat)!
04.12.2025 13:05 β π 0 π 0 π¬ 0 π 0
Oral Vancomycin "Tail" Offers No Added Benefit for CDI Prophylaxis
At MAD-ID 2025, Jiye Park, PharmD, presents findings showing once-daily dosing is effective, with no added benefit from extended vancomycin use after antibiotics.
π₯ At #MADID2025, Dr. Jiye Park from Massachusetts General Hospital shared data showing no added benefit from extending oral vancomycin after systemic antibiotics for CDI prophylaxis. @mad-id.bsky.social #IDsky #MEDsky
Listen to more of the results here: www.contagionlive.com/view/oral-va...
31.05.2025 13:08 β π 6 π 3 π¬ 0 π 2
Following and will revisit when we transition to epic spring 2027 ππ»
30.05.2025 21:58 β π 1 π 0 π¬ 0 π 0
At little late to post, but I love being an ID Pharmacist working to preserve antimicrobials through education, collaboration, and direct patient care! π+π¦ #IDPharmacistsDay #SIDPAdvocacy #FutureOfIDPharmacy #PharmacistsLeadingChange @sidpharm.bsky.social
23.05.2025 01:18 β π 56 π 8 π¬ 3 π 0
Nothing is better than seeing this study published just in time for ID Pharmacists Day! π₯³ #IDSky
19.05.2025 23:45 β π 22 π 4 π¬ 0 π 0
π‘ A: In stable FN patients with persistent fever of unknown origin, current NCCN and ECIL guidelines do not recommend changing empiric coverage for Gram-negative bacteria.
β³ Time to defervescence may last 2-7 days (median of 5 days) for patients on appropriate initial antibiotic therapy. (3)
20.05.2025 16:37 β π 2 π 2 π¬ 1 π 0
FDA will limit Covid vaccines to people over 65 or at high risk of serious illness, leaders say
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness
GUYS. The comment period for this ends in THREE DAYS. PLEASE if you have even a little bit of time, submit a comment here: www.regulations.gov/commenton/FD...
Let them know EVERYONE should be able to get COVID vaccines. They BACK DOWN when WE PUSH BACK. www.statnews.com/2025/05/20/f...
20.05.2025 19:36 β π 6858 π 6528 π¬ 547 π 588
Unfortunately and unsurprisingly, the administration continues to charge ahead, running roughshod over norms, laws, and the dignity of and most basic protections for the people most vulnerable to infections. Many of the changes are summarized here, up to date as of Feb 4. Who will speak up, or better still, ACT UP for these individuals?
The National Science Foundation has reportedly shared with program officers a list of forbidden "DEI"-related words that will result in grants being flagged. These include routinely used terms like "female", "biased", "systemic", "inclusion" and "exclusion" along with other words that specifically target vulnerable populations. While few clinical researchers rely on NSF grants, it can be reasonably expected that similar censorship with grants from NIH, CDC, etc is inevitable.
USAID funding remains frozen, and in fact there are reports of efforts underway to eliminate the entire agency. The effects have already been devastating for programs dedicated to controlling TB, malaria, and HIV, among others. Despite claims that these would be exempt, distribution of antiretrovirals remains frozen.
The Senate Finance committee advanced RFK Jr for confirmation as HHS Secretary. Kennedy's disdain for evidence-based medicine is no secret. He is a conspiracy theorist who engages in dangerous race-based pseudoscience. The IDSA has fallen short of other professional societies (e.g. the American Public Health Association, which represents 25,000 public health professionals) in calling for the outright rejection of RFK Jr's nomination.
The CDC and NIH remain muzzled, unable to communicate with interstate or international agencies or the public. They have been instructed to recall submitted or accepted manuscripts to scrub objectionable language. They remain barred from traveling until at least the end of April. How will these actions affect our ability to detect and respond to infectious disease outbreaks?
Meanwhile, our members are experiencing significant moral injury, and some have expressed levels of morale that rival the nadirs felt during the worst of COVID19. Every day it is a new insult, the cumulative effect being the disassembly of public health protections and further marginalization of the most vulnerable in society.
Reticence to call attention to ourselves, potentially putting our work in the administration's cross hairs, is entirely understandable. After all, we don't want to imperil existing and ongoing advocacy efforts, including those related to bolstering the ID workforce. A sober analysis would concede that the likelihood of any potential actions moving the needle on any of these issues is low. I would argue, however, that standing up for what is right is the most important thing we can do to reinforce our commitment to social justice and to our members and the patients in our care.
What we can do and how we can do it is up for debate; some bold ideas have already been presented in the IDea exchange forum and I welcome further input from colleagues. What is certain is that as rank-and-file individuals, our voices can easily be dismissed, but as a trusted, bipartisan professional organization that represents >13,000 infectious diseases experts, we cannot be ignored, and we must not allow ourselves to cower in silence. The reality is that things are going to get worse, and standing up to the assault on public health will only get more difficult as the administration becomes further emboldened and the actions set in motion gather steam.
In the words of John Lewis, "If not us, then who? If not now, then when?"
I am deeply disappointed by the subdued response of the Infectious Diseases Society of America (@idsainfo.bsky.social) to the dismantling of public health structures, both in the US & globally
Here's what I wrote in the closed listserv (response: π¦) in hopes of stimulating discussion here #IDSky
07.02.2025 18:32 β π 309 π 90 π¬ 14 π 2
Summary of new antibiotic agents for the treatment of MDR Gram negative bacterial infections
doi.org/10.1016/S014...
#IDSky
17.01.2025 12:46 β π 29 π 13 π¬ 4 π 2
Greatπ§΅on Norovirus
Illness duration short & miserable, but it survives in the environment (think ππ§©π§Έππ©Ί) for 7-12βd
Norovirus reproduction # is ~3-12, meaning each infected person infects 3-12 othersπ³ (12 is usually schools, daycares)
05.01.2025 03:23 β π 3 π 1 π¬ 0 π 0
Interested in SIDPβs Antimicrobial Stewardship Certificate Program? To see the program description and to register, please visit buff.ly/3NXfAKW' #IDSky #MedSky @sidpharm.bsky.social
12.11.2024 23:25 β π 21 π 10 π¬ 2 π 0
a man in a suit and tie stands in front of a group of people and says there are dozens of us
Alt: Tobias FΓΌnke standing if front of a crowd in a brown suit, yelling "There are dozens of us. DOZENS!" while pointing to the sky
#IDSky Starter Packs (Updated 11/11/24)
IDSky 1 go.bsky.app/LnAQjdq
IDSky 2 go.bsky.app/JNfSvQT
IDSky 3 go.bsky.app/FeogT7o
IDSky 4 go.bsky.app/D1zxj4E
TxID go.bsky.app/95rzmLi
MedMycology go.bsky.app/8XGywEx
Let me know if I missed you! cc #MedSky
11.11.2024 21:55 β π 108 π 51 π¬ 32 π 5
Please join for our MedStar pharmacy residency open house November 22 from 11am-2pm ET! Zoom link:
us05web.zoom.us/j/8484514365...
12.11.2024 18:08 β π 1 π 0 π¬ 0 π 0
Wishlist #IDsky ;
-IDJclub resurrection
-ABsteward (Bassam Guanem)
-IdVilchez (Gabe)
-Brad Spellberg
-FungalDoc (Andrej Spec)
-Darcy_ID_doc (Darcy Wooten)
-Paul Sax
-Monica Ghandi
-Carlos del Rio
08.11.2024 12:34 β π 31 π 3 π¬ 8 π 0
Can colleagues amplify this appeal to journals and journal editors to open accounts on Bluesky, please? @MicrobioSoc @TrendsMicrobiol @CellCellPress @JBacteriology @jbiolchem @Nature @ScienceMagazine @PNASNews @MolMicroEditors @NAR_Open @NatureMicrobiol @NatureComms @ASMicrobiology π
π¦ π§ͺπ§«π§¬
10.11.2024 13:13 β π 271 π 209 π¬ 18 π 5
Who is still using metronidazole q8h for most indications? Thereβs definitely an opportunity for less frequent dosing most of the time!
Iβve attached my proposal from last year - feel free to take a look, and hopefully it can save you some trouble and doses for you too!
1drv.ms/w/s!AurvlEJP...
10.11.2024 17:14 β π 41 π 9 π¬ 16 π 1
π¬ Assistant Prof, Pathology βͺ@Duke | Director, Clin Micro Lab
π§« Former Clin Micro Fellow βͺ@Memorial Sloan Kettering
π©π»βπ¬ Former Postdoc @broadinstitute.org
π PhD @The Rockefeller University
Focus: Diagnostics, AMR, Structural Biology
This is the Blue Sky account for the Proudly ID Interest Group of IDSA. Follow along for updates about our group!
We lead in Infectious Diseases through bold exchange of knowledge, amplifying scientific discovery, and empowering infectious diseases pharmacists, trainees, and clinicians. #MADID2025
https://www.mad-id.org/
ID pharmacist @ University Health San Antonio, TX
Transplant ID physician with interest in #HBV, health policy and medical leadership
ID Instructor at Weill Cornell Medicine.
Interested in Transplant ID, Antimicrobial Resistance, and MedEd.
Any opinions my own / do not represent my employer.
Information from our community of Infectious Diseases physicians, pharmacists, scientists, students and experts interested in Transplant Infectious Diseases in the Southeast US region
UAB | Duke | UNC | Emory | UTSW | Ochsner | MUSC | VCU | Tulane | VUMC
Assistant Clinical Professor at City of Hope | transplant ID trained at UCLA | med+peds & ID trained at USC | daughter of a transplant pt | Sri Lankan-American
Transplant/Oncology Infectious Diseases Physician-Scientist. Virologist. Dad. Homebrewer. Casual birder. #IDSky
The official Bluesky account for http://transplantid.net, the AST @astinfo.bsky.social ID COP @ast-idcop.bsky.social Transplant Infectious Diseases Library
Posts made by this account are not endorsed and may not reflect the views of AST.
I study evolution in fungi using genomics at UC Riverside. He/him.
Tongva, Cahuilla, Serrano lands
http://lab.stajich.org/
Junior group leader at the University of Jena (@uni-jena.de)
CIFAR Azrieli Global Scholar
Fungal pathoecology, antimicrobial resistance, and genome stuff.
Always up for an adventure or bike ride.
https://barber-lab.com
Associate professor in microbiology | fungal pathogenesis + genetics | UMichigan
Associate Professor of Microbiology UMN Twin Cities. Fungal pathogen research on genome instability, aneuploidy, polyploidy, and drug resistance. Dog mom. Fiddle player. T1D. First gen.
- Prin Scientific Officer, NCID, Singapore
- Asst Prof @UBC Canada
- Asst Prof @NTU Singapore
- views are my own
- Editor, tea lover, hiker
#microbiology #mycology #evolutionarybiology #genomics #AMR
UC-Berkeley Postdocπ», Edison Scientific Consultantπ¨π½βπ», Evomics Workshop Codirectorπ§¬
prev Vanderbilt PhD, FutureHouse, Latch, MantleBio (acquired)
π² https://linktr.ee/jlsteenwyk
π https://jlsteenwyk.com/
π΅π·π³οΈβπ | Asst. Prof. @ Virginia Tech | UPRM & DukeMGM Alumnus | He/His/Him | Opinions are my own, RT β endorsements. πβ£οΈπ§« Website: jvm-lab.weebly.com